title: [Successful midodrin treatment for vasovagal syncopes accompanied by asystole].
abstract: Vasovagal syncopes (WS) are fainting fits whose manifestations are systemic vasodilation and bradycardia. The development of WS is frequently accompanied by short-term cardiac arrest. Recent data show that implantation of a cardiac pacemaker fails to prevent the development of fainting fits in these patients. On the basis of the pathogenesis of WS, the use of alpha-adrenomimetic midodrine is justifiable. The presented case demonstrates the successful use of the agent in the treatment of vasovagal syncope accompanied by asystole.
authors.forename: A V
authors.initials: AV
authors.lastname: Pevzner
authors.forename: E A
authors.initials: EA
authors.lastname: Kuchinskaia
authors.forename: E V
authors.initials: EV
authors.lastname: Vershuta
authors.forename: K V
authors.initials: KV
authors.lastname: Al'bitskaia
authors.forename: G I
authors.initials: GI
authors.lastname: Kheĭmetz
authors.forename: M I
authors.initials: MI
authors.lastname: Tripoten'
authors.forename: A N
authors.initials: AN
authors.lastname: Rogoza
authors.forename: S P
authors.initials: SP
authors.lastname: Golitsyn
mesh_terms: D000316:Adrenergic alpha-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use; D004562:Electrocardiography; D006323:Heart Arrest / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006336:Heart Massage; D006801:Humans; D008297:Male; D008879:Midodrine / Q000008:administration & dosage / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D019462:Syncope, Vasovagal / Q000150:complications* / Q000188:drug therapy*; D013997:Time Factors
chemical_list: D000316:Adrenergic alpha-Agonists; D018727:Muscarinic Antagonists; D008879:Midodrine; D001285:Atropine